Immunotherapy of biliary tract cancer. - Wikidata - awgldk - TriplyDB

Immunotherapy of biliary tract cancer.

Immunotherapy of biliary tract cancer.

http://www.wikidata.org/entity/Q38686339

about

High CD8+ and absence of Foxp3+ T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival.

P2860

Q54934803-CA16AB15-34AB-4C9D-B011-1AAACD8A0290

P2860

Immunotherapy of biliary tract cancer.

http://www.wikidata.org/entity/Q38686339

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Immunotherapy of biliary tract cancer.

@en

type

label

Immunotherapy of biliary tract cancer.

@en

prefLabel

Immunotherapy of biliary tract cancer.

@en

P1433

Q38686339-E68B3D18-830B-4DDF-B357-C5F06A9C1C64

P1476

Q38686339-C6505FA4-05EE-48DF-9CEE-337B7CB0E7BD

P2093

Q38686339-1D88F17D-C820-4377-AB3B-9466E3A3DEFB

P2860

Q38686339-075166A0-AD48-4B96-B2B1-637F10B458F2

Q38686339-08F2B9F0-39A0-4C75-AAF1-374ED6AA24B3

Q38686339-0D74DAAD-7A84-41DC-A4EF-B13A63C152F2

Q38686339-0FBEC9EA-94F7-4D7D-B47A-DFFB61568B4D

Q38686339-21B73E40-822C-49A8-BADB-E6B04A58BC40

Q38686339-22A85725-D647-40AC-8EF6-05A870646FD3

Q38686339-3AB32FBD-FC7E-43D2-8E2D-B93E4C6A56F9

Q38686339-3E1407D8-A641-4C36-AF4F-92FAC7FE0194

Q38686339-5699CAF0-814D-4B44-8522-CDF47F3FE0A3

Q38686339-57D0DD98-59D7-4986-BADB-F85763A149DC

P2888

Q38686339-E5D31E3D-F46C-4CDC-A5CF-6DE066A99D09

P304

Q38686339-83A3EDD9-2CD4-4386-8790-51AE6D06A3E0

P31

Q38686339-656510E6-3873-4DC7-BF83-A32945E2CAC7

P356

Q38686339-560B292F-9648-4D5D-8A20-6E72B5EC8E15

P433

Q38686339-99DC9FE2-8947-44A3-BCBD-9BF2DC03427A

P478

Q38686339-F66C41A5-2669-4C2B-89A1-A349F15AAC7F

P577

Q38686339-ADB9FBEA-B89B-457B-A6C3-D524FE8175E2

P6179

Q38686339-FE5CDA61-6275-413C-AC36-A2CC4EEF1259

P698

Q38686339-30E893EF-3635-4A8A-8C77-A6D9EEC39AA9

P921

Q38686339-4C460D92-D927-4052-88B0-147F6AF4B1E0

P356

S13277-015-4743-X

P1433

P1476

Immunotherapy of biliary tract cancer.

@en

P2093

Yi Chai

http://www.w3.org/2001/XMLSchema#string

P2860

Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.

Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer

Cholangiocarcinoma.

Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study.

IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma.

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway.

B7-H1 pathway and its role in the evasion of tumor immunity.

Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.

P2888

s13277-015-4743-x

P304

2817-2821

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-4743-X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1026900182

http://www.w3.org/2001/XMLSchema#string

P698

26729196

http://www.w3.org/2001/XMLSchema#string

P921